Synthetic approaches to site selective deuterium incorporation in a novel CRTh2 receptor antagonist clinical candidate.
Selection of acidic or basic reaction conditions, combined with appropriate temperatures, allowed for site selective direct incorporation of deuterium at multiple positions in the 7-azaindole-3-acetic acid CRTh2 receptor antagonist clinical candidate NVP-QAV680.